🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NUV
$NUVB
🔒 US EquitiesNuvation Bio Inc
AVG HISTORICAL GAP
-1.07%
MAX GAP RECORD
-17.64%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NUVB
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NUVB
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN) |
-4.87%
|
| May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE) |
+2.48%
|
| Mar 02, 2026 Earnings Release 2026-03-02 (AFTER CLOSE) |
-17.64%
|
| Nov 03, 2025 Earnings Release 2025-11-03 (AFTER CLOSE) |
-0.39%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN) |
-0.85%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+8.82%
|
| Mar 06, 2025 Earnings Release 2025-03-06 (AFTER CLOSE) |
+0.00%
|
| Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE) |
+1.57%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.5%
Bullish Gaps (5)
Bearish Gaps (4)
Neutral / Flat (3)
📖 Intelligence Summary
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗